REGENEREX PHARMA, INC (RGPX) Operating income 2016–2024
REGENEREX PHARMA, INC (RGPX) annual operating income history from SEC filings — each fiscal year as reported.
-$1.8MFY2024 · since FY2016: -$2,573 → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.8M | +47.3% |
| FY2023 | -$3.5M | -3503.8% |
| FY2022 | -$96,171 | +23.8% |
| FY2021 | -$126,267 | -190.9% |
| FY2020 | -$43,411 | +43.6% |
| FY2019 | -$77,003 | +16.1% |
| FY2018 | -$91,734 | -85.5% |
| FY2017 | -$49,451 | -1821.9% |
| FY2016 | -$2,573 | — |
Source: SEC XBRL filings · For reference only · Not investment advice